Our results were in agreement with our observations in NSCLC specimens, indicating the expression of NCAPD3 was significant upregulated in lung cancer cell lines, especially in the A549 and SPCA-1 (Fig. 2a, b). This evidence concerns the gene NCAPD3 and lung carcinoma.